| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |